We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
UBM | LSE:UBM | London | Ordinary Share | JE00BD9WR069 | ORD 11.25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1,080.00 | 1,074.00 | 1,076.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
BOSTON, Nov. 29, 2017 /PRNewswire/ -- Cat Greenleaf, creator/host of the award-winning series Talk Stoop on both NBC & USA Networks is confirmed to deliver the keynote address at the 14th Annual Pharma Forum Conference to take place on March 25-28, 2018 in Philadelphia.
KEYNOTE ADDRESS: The Power of Communication — Infuse Stronger Connections through Practiced Techniques to Develop More Valuable Relationships
The mom, wife, pet collector, adoption advocate, and interview guru will share her insights from the stoop, discussing the importance of meaningful conversation and how to navigate the world of words to create an environment of impactful negotiation to gain solution-oriented results. She will also highlight her cultivated techniques for improving communication to propel relationships forward.
Cat Greenleaf's series, Talk Stoop, has featured conversations with A-List actors including Sir Ian McKellen, Sir Patrick Stewart, Don Cheadle, Woody Harrelson, Mick Jagger, Kareem Abdul-Jabaar, Arianna Huffington, Claire Danes, Dan Rather, Katie Holmes, every Kardashian possible, Selena Gomez, Wilco, the Muppets, Tony Robbins, Joel Osteen, JLO, Dick Cavett, Elliot Spitzer, Jesse Jackson, Rahm Emmanuel, Dan Ackroyd, Heather Graham, A-Rod, Mike Tyson, Kate Hudson, Martha Stewart, James Spader, Michael Strahan, Barry Manilow, Alan Cumming, Nas, Orlando Bloom and Michael J. Fox.
"We are thrilled to announce Talk Stoop's Cat Greenleaf keynoting the conference," says Melanie Demakis, Senior Program Director of Pharma Forum 2018. "Meeting planners from all over the world come to Pharma Forum and will benefit from Greenleaf's insight on improving conversations to enhance negotiation and professional communication," Demakis adds. In its 14th annual installment, the 2018 Pharma Forum conference is a three-day event connecting corporate and third-party planners with supplier partners in a highly collaborative networking and educational environment to build relationships, share insights, brainstorm solutions and discuss the future of meeting compliance, technology, experiences and more. Registration for the early bird promotion expires Friday December 15: www.pharmameetingplanners.com
Agenda Highlights for Pharma Forum 2018
Check out the full agenda here:
http://www.cbinet.com/pharmaforum-agenda
. Over 35 distinguished meeting management experts will provide key insights on topics during:
Confirmed Thought Leaders at Pharma Forum 2018:
Pharma Forum 2018 Advisory Committee:
Act Fast – Early-Bird registration ends December 15!
Access the special promotion pricing here: https://www.cbinet.com//conference-registration-form?conference=pc18086
Stay tuned for updates and announcements by following us on social media:
Twitter: @PharmaForum_CBI and #PharmaForum
Facebook: @PharmaForum
LinkedIn: Pharmaceutical Meeting Planners
Or subscribe to the Pharma Forum newsletter for updates and industry resources straight to your inbox.
Media contact:
Sabrina Delio
Senior Marketing Manager
Phone: 339-298-2285
Sabrina.Delio@cbinet.com
View original content:http://www.prnewswire.com/news-releases/creatorhost-of-the-award-winning-series-talk-stoop-to-present-keynote-at-14th-annual-pharma-forum-conference-300563660.html
SOURCE Pharma Forum
Copyright 2017 PR Newswire
1 Year UBM Chart |
1 Month UBM Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions